159 related articles for article (PubMed ID: 2658877)
21. Antimalarial drug response of Plasmodium falciparum from Zaria, Nigeria.
Adagu IS; Warhurst DC; Ogala WN; Abdu-Aguye I; Audu LI; Bamgbola FO; Ovwigho UB
Trans R Soc Trop Med Hyg; 1995; 89(4):422-5. PubMed ID: 7570886
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire.
Wolday D; Kibreab T; Bukenya D; Hodes R
Trans R Soc Trop Med Hyg; 1995; 89(6):654-6. PubMed ID: 8594686
[TBL] [Abstract][Full Text] [Related]
23. Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988.
Hansford CF
S Afr Med J; 1989 Nov; 76(10):546-7. PubMed ID: 2686047
[TBL] [Abstract][Full Text] [Related]
24. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
Tall A; Rabarijaona LP; Robert V; Bedja SA; Ariey F; Randrianarivelojosia M
Acta Trop; 2007 Jun; 102(3):176-81. PubMed ID: 17568549
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
Del Nero L; Lamizana L; Pietra V; Nebié I
Parassitologia; 1994 Dec; 36(3):287-93. PubMed ID: 7637999
[TBL] [Abstract][Full Text] [Related]
27. Assessment of susceptibility of Plasmodium falciparum to chloroquine, quinine, mefloquine, sulfadoxine-pyrimethamine and artemisinin in southern Viet Nam.
Thanh NV; Cowman AF; Hipgrave D; Kim TB; Phuc BQ; Cong LD; Biggs BA
Trans R Soc Trop Med Hyg; 2001; 95(5):513-7. PubMed ID: 11706663
[TBL] [Abstract][Full Text] [Related]
28. Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet Province, Lao People's Democratic Republic: an assessment of national antimalarial drug recommendations.
Mayxay M; Newton PN; Khanthavong M; Tiengkham P; Phetsouvanh R; Phompida S; Brockman A; White NJ
Clin Infect Dis; 2003 Oct; 37(8):1021-8. PubMed ID: 14523765
[TBL] [Abstract][Full Text] [Related]
29. Assessing the efficacy of chloroquine and sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo.
Kazadi WM; Vong S; Makina BN; Mantshumba JC; Kabuya W; Kebela BI; Ngimbi NP
Trop Med Int Health; 2003 Oct; 8(10):868-75. PubMed ID: 14516297
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of four therapeutic regimens for falciparum malaria in Mozambique, 1986.
Schapira A; Schwalbach JF
Bull World Health Organ; 1988; 66(2):219-26. PubMed ID: 3293827
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
Ghosh SK; Yadav RS; Sharma VP
Indian J Malariol; 1992 Dec; 29(4):211-8. PubMed ID: 1291342
[TBL] [Abstract][Full Text] [Related]
32. Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
Obua C; Gustafsson LL; Aguttu C; Anokbonggo WW; Ogwal-Okeng JW; Chiria J; Hellgren U
Acta Trop; 2006 Nov; 100(1-2):142-50. PubMed ID: 17113554
[TBL] [Abstract][Full Text] [Related]
33. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of artemether (qinghaosu) in Plasmodium falciparum and P. vivax in Burma.
Pe Than Myint ; Tin Shwe
Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):19-22. PubMed ID: 3526578
[TBL] [Abstract][Full Text] [Related]
35. Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
Nevill CG; Ochen K; Munafu CG; Bekobita D; Sezi CL
East Afr Med J; 1995 Jun; 72(6):349-54. PubMed ID: 7498001
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.
Marquiño W; MacArthur JR; Barat LM; Oblitas FE; Arrunátegui M; Garavito G; Chafloque ML; Pardavé B; Gutierrez S; Arróspide N; Carrillo C; Cabezas C; Ruebush TK
Am J Trop Med Hyg; 2003 Jan; 68(1):120-3. PubMed ID: 12557836
[TBL] [Abstract][Full Text] [Related]
37. Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar.
Al-Yaman F; Genton B; Mokela D; Alpers MP
P N G Med J; 1994 Mar; 37(1):54-6. PubMed ID: 7863730
[No Abstract] [Full Text] [Related]
38. Current clinical efficacy of chloroquine for the treatment of Plasmodium falciparum infections in urban Dar es Salaam, United Republic of Tanzania.
Premji Z; Makwaya C; Minjas JN
Bull World Health Organ; 1999; 77(9):740-4. PubMed ID: 10534897
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of a 3-day oral regimen of quinine in an area of northern Nigeria with low-grade resistance of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine.
Adagu SI; Okoyeh JN; Lege-Oguntoye L; Ogala WN; Ogunrinde GO; Faji JT; Sani AH
J Trop Med Hyg; 1995 Oct; 98(5):296-8. PubMed ID: 7563254
[TBL] [Abstract][Full Text] [Related]
40. Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change.
Basco LK; Ngane VF; Ndounga M; Same-Ekobo A; Youmba JC; Abodo RT; Soula G
Am J Trop Med Hyg; 2006 Sep; 75(3):388-95. PubMed ID: 16968911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
